COX7B
protein-codingcytochrome c oxidase subunit 7B, the group of Mitochondrial complex IV: cytochrome c oxidase subunits
Gene summary
Cytochrome c oxidase (COX), the terminal component of the mitochondrial respiratory chain, catalyzes the electron transfer from reduced cytochrome c to oxygen. This component is a heteromeric complex consisting of 3 catalytic subunits encoded by mitochondrial genes and multiple structural subunits encoded by nuclear genes. The mitochondrially-encoded subunits function in electron transfer, and the nuclear-encoded subunits may function in the regulation and assembly of the complex. This nuclear gene encodes subunit VIIb, which is highly similar to bovine COX VIIb protein and is found in all tissues. This gene may have several pseudogenes on chromosomes 1, 2, 20 and 22. [provided by RefSeq, Jun 2011]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~7.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: XL
Disease ID:MONDO:0010672
Submitter: Orphanet
Inheritance Pattern: XL
Disease ID:MONDO:0010474
Submitter: G2P
Inheritance Pattern: XL
Disease ID:MONDO:0044970
Submitter: ClinGen
The relationship between *COX7B* and primary mitochondrial disease was evaluated using the ClinGen Clinical Validity Framework as of September 30, 2024. The *COX7B* gene encodes the cytochrome *c* oxidase (complex IV) subunit 7B. The first and only report of the *COX7B* gene in relation to X-linked primary mitochondrial disease was in 2012 (PMID: 23122588). *COX7B* has been associated with a single disease entity to date; linear skin defects with multiple congenital anomalies 2 [OMIM# 300887]. This is one disease entity according to the ClinGen Lumping and Splitting Framework, and is considered a primary mitochondrial disease. Evidence supporting this gene-disease relationship includes case-level data and experimental data. This curation included three variants (one nonsense, one frameshift, one splice acceptor) identified in three unrelated female probands from one publication (PMIDs: 23122588). All three probands had microcephaly, linear skin lesions on the face and neck, and poor growth. The mother of one proband also had the variant and presented at birth with linear skin defects. Additional features seen in the probands include intellectual disability, learning disability, and short stature. The mechanism of disease is loss of function. This gene-disease relationship is also supported by a biochemical function shared with other genes associated with primary mitochondrial disease (PMID: 33340416), functional studies in HeLa cells (PMID: 23122588), and a medaka fish model (PMID: 23122588). In summary, there is moderate evidence to support the relationship between *COX7B* and X-linked primary mitochondrial disease. However, this Expert Panel elected to downgrade the classification to limited as biochemistry was not performed in the probands, and because almost all of the evidence comes from one publication. While more evidence is needed to establish this relationship definitively, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on September 30, 2024 (SOP Version 10).
Inheritance Pattern: XL
Disease ID:MONDO:0010474
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Ophthalmologic; Renal
Intervention: Cardiovascular
Rationale: The condition can involve congenital cardiac anomalies, and awareness may allow early management
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to COX7B variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001866.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 4 | 6 | |||
| missense | 13 | 5 | 1 | 19 | ||
| nonsense | 1 | 1 | 2 | |||
| start loss | 1 | 1 | ||||
| frameshift | 1 | 1 | ||||
| splice donor/acceptor (+/-2bp) | 1 | 2 | 3 | |||
| Total | 3 | 0 | 19 | 9 | 1 | 32 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001857.1 | 3 | MANE Select | |
| Ensembl | ENSP00000497474.1 | 3 | MANE Select | |
| Ensembl | ENSP00000496880.1 | 2 | Standard | |
| Ensembl | ENSP00000496880.1 | 2 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Cardiac muscle contraction - Homo sapiens (human)
- Non-alcoholic fatty liver disease (NAFLD) - Homo sapiens (human)
- Alzheimer,s disease - Homo sapiens (human)
- Huntington,s disease - Homo sapiens (human)
- Thermogenesis - Homo sapiens (human)
Biological Process
- central nervous system development
- electron transport chain
- proton transmembrane transport
Molecular Function
- cytochrome-c oxidase activity
Cellular Component
- mitochondrial inner membrane
- mitochondrial respirasome
- integral component of membrane
- respiratory chain complex IV
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000481445
- Coding exons
- 3
- Length
- 7936
- Individuals with no LoFs
- 0
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 0
- Defined
- 0
- p
- 0.00
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.424 | 25 | 31.7 | 0.788 | 0.00000240 | 521 |
| Missense (PolyPhen) | 2 | 6.7873 | 0.29467 | 159 | ||
| Synonymous | -0.763 | 14 | 10.8 | 1.30 | 8.27e-7 | 149 |
| Loss of Function | 1.77 | 0 | 3.66 | 0.00 | 2.87e-7 | 49 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0 | 0.0 | absent |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: This protein is one of the nuclear-coded polypeptide chains of cytochrome c oxidase, the terminal oxidase in mitochondrial electron transport. Plays a role in proper central nervous system (CNS) development in vertebrates. {ECO:0000269|PubMed:23122588}.;
- Disease
- DISEASE: Linear skin defects with multiple congenital anomalies 2 (LSDMCA2) [MIM:300887]: A distinct form of aplasia cutis congenita presenting as multiple linear skin defects on the face and neck associated with poor growth, microcephaly, and facial dysmorphism. Additional features include intellectual disability, nail dystrophy, short stature and cardiac abnormalities. {ECO:0000269|PubMed:23122588}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.0840
Intolerance Scores
- RVIS EVS
- 0.28
- RVIS percentile EVS
- 70.87
Essentials
- Essential (CRISPR)
- N
- Essential (gene trap)
- E
- Indispensability pred.
- E
- Indispensability score
- 0.819
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |